XML 30 R19.htm IDEA: XBRL DOCUMENT
v3.21.2

Related Party Transactions (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2021
Related Party Transactions [Abstract] |
Schedule of Incurred Expenses of Minority Shareholders | Schedule of Incurred Expenses of Minority Shareholders
|  | For the three months ended September 30, |  |  | For the nine months ended September 30, |
|  | 2021 |  |  | 2020 |  |  | 2021 |  |  | 2020 |
Cost of Revenue |  |  |  |  |  |  |  |  |  |  |  |
CWRU – Royalty Fee |  | $ | 10,000 |  |  | $ | — |  |  | $ | 10,000 |  |  | $ | — |
General and Administrative Expense |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
CWRU – License Agreement - Amendment Fee - Milestone III |  |  | 10,000 |  |  |  | — |  |  |  | 10,000 |  |  |  | — |
Stock-based compensation expense – Physician Inventors’ restricted stock awards |  |  | 273,000 |  |  |  | — |  |  |  | 637,000 |  |  |  | — |
Research and Development Expense |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
CWRU License Agreement - reimbursement of patent legal fees |  |  | 82,400 |  |  |  | 79,497 |  |  |  | 195,363 |  |  |  | 138,381 |
EsoCheck devices provided to CWRU |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 14,941 |
Fees - Physician Inventors’ consulting agreements |  |  | 8,035 |  |  |  | 20,455 |  |  |  | 21,950 |  |  |  | 73,875 |
Stock-based compensation expense – Physician Inventors’ stock options |  |  | 55,455 |  |  |  | 5,750 |  |  |  | 113,584 |  |  |  | 17,250 |
Total Related Party Expenses |  | $ | 438,890 |  |  | $ | 105,702 |  |  | $ | 987,897 |  |  | $ | 244,447 |
Schedule of MSA Fee Expense Classification in Unaudited Condensed Statement of Operations | Schedule of MSA Fee Expense Classification in Unaudited Condensed Statement of Operations
|  | Cost of |  |  | Commercial |  |  | General & |  |  | Research & |  |  | Total |
MSA Fee - Three Months Ended |  | Revenue |  |  | Operations |  |  | Administrative |  |  | Development |  |  | MSA Fee |
- March 31, 2021 |  | $ | — |  |  | $ | 323,400 |  |  | $ | 269,500 |  |  | $ | 177,100 |  |  | $ | 770,000 |
- June 30, 2021 |  |  | — |  |  |  | 295,800 |  |  |  | 348,000 |  |  |  | 226,200 |  |  |  | 870,000 |
- September 30, 2021 |  |  | 39,682 |  |  |  | 352,055 |  |  |  | 254,575 |  |  |  | 223,688 |  |  |  | 870,000 |
Total - Nine Months Ended |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
September 30, 2021 |  | $ | 39,682 |  |  | $ | 971,255 |  |  | $ | 872,075 |  |  | $ | 626,988 |  |  | $ | 2,510,000 |
|  | Cost of |  |  | Commercial |  |  | General & |  |  | Research & |  |  | Total |
MSA Fee - Three Months Ended |  | Revenue |  |  | Operations |  |  | Administrative |  |  | Development |  |  | MSA Fee |
- March 31, 2020 |  | $ | — |  |  | $ | 43,200 |  |  | $ | 118,800 |  |  | $ | 108,000 |  |  | $ | 270,000 |
- June 30, 2020 |  |  | — |  |  |  | 56,700 |  |  |  | 118,800 |  |  |  | 94,500 |  |  |  | 270,000 |
- September 30, 2020 |  |  | — |  |  |  | 148,200 |  |  |  | 245,100 |  |  |  | 176,700 |  |  |  | 570,000 |
Total - Nine Months Ended |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
September 30, 2020 |  | $ | — |  |  | $ | 248,100 |  |  | $ | 482,700 |  |  | $ | 379,200 |  |  | $ | 1,110,000 |

X
- Definition Tabular disclosure of condensed income statement, including, but not limited to, income statements of consolidated entities and consolidation eliminations. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 3 -Paragraph i -Subsection 10 + Details
Name: | srt_ScheduleOfCondensedIncomeStatementTableTextBlock
Namespace Prefix: | srt_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_RelatedPartyTransactionsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of related party transactions. Examples of related party transactions include, but are not limited to, transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners and (d) affiliates. + References No definition available. + Details
Name: | us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration